Want to join the conversation?
$FSLR's net cash provided by operating activities for 1Q16 was $50.49MM compared to cash used in operating activities of $424.62MM last year. Net cash used in investing activities fell to $110.65MM from $290.63MM in the prior year quarter. Net cash provided by financing activities decreased to $13.18MM from $27.26MM a year ago.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.